Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2010
11/03/2010CN101874841A Total glycosides extractive of morinda plants, as well as preparation method and application thereof
11/03/2010CN101874840A Total polysaccharide extractive of morinda plants as well as preparation method and application thereof
11/03/2010CN101874839A Total effective extractive part of morinda officinalis, as well as preparation method and application thereof
11/03/2010CN101874828A Chinese medicinal antiphlogistic pill
11/03/2010CN101874824A Active extract containing trilobatin and application thereof
11/03/2010CN101874817A Brucea javanica oil enteric-coated microcapsule, preparation method and application thereof
11/03/2010CN101874808A Azithromycin compound medicament
11/03/2010CN101874778A Alpha-asarone spraying agent and preparation method thereof
11/03/2010CN101874774A Suspension composition containing lysozyme and florfenicol and preparation method thereof
11/03/2010CN101579186B Pharmaceutical rhinitis pillow for external use and treating wind-heat rhinitis
11/03/2010CN101314015B Medicament for treating children's asthma
11/03/2010CN101297826B Compound Bupleurum injection for curing common cold of dog and preparation thereof
11/03/2010CN101264242B Medicaments preparations for treating hemorrhage, pain and dropsy
11/03/2010CN101181357B Detection method of chlorphenamine Maleate of ketelin lozenge
11/03/2010CN101167871B Compound pearl lozenge and preparation method and application thereof
11/03/2010CN101095656B Application of Andrographis paniculata in the preparation of tooth cleaning articles and the tooth cleaning articles thereof
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825219 Binding protein; therapy for bone tumors
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7825105 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
11/02/2010US7825095 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/02/2010US7824696 Modified nucleotides for immunotherapy; induce immunology response; consisting of nucleoside methylphosphonate and 2'-O-methyl-ribonucleoside groups
11/02/2010US7824683 Methods for augmenting an immune response using anti-CD40 antibodies
11/02/2010CA2462799C Pyrimidine derivatives
11/02/2010CA2439784C Pyrazolopyrimidinone derivatives having pde7 inhibiting action
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2417432C Modified polypeptides stabilized in a desired conformation and methods for producing same
11/02/2010CA2337422C Preventing airway mucus production by administration of egf-r antagonists
10/2010
10/28/2010WO2010124141A1 Methods of treating a pulmonary bacterial infection using fluoro-quinolones
10/28/2010WO2010124058A1 Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
10/28/2010WO2010123956A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010WO2010123766A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
10/28/2010WO2010123037A1 Agent for regulating composition ratio of intestinal bacterial flora
10/28/2010WO2010122089A1 N-pyrazolyl carboxamides as crac channel inhibitors
10/28/2010WO2010122088A1 Pyrazole and triazole carboxamides as crac channel inhibitors
10/28/2010WO2010121618A1 A tuberculosis tb vaccine to prevent reactivation
10/28/2010WO2010077882A3 Antagonists of lysophosphatidic acid receptors
10/28/2010WO2010068754A3 Methods and compositions for delivery of medicaments to the lungs
10/28/2010US20100273887 Mixtures comprising pellitorin and uses thereof
10/28/2010US20100273868 R-Zileuton for Use in Conditions Associated with Increased 5-Lipoxygenase and/or Leukotriene Activity (EG Asthma)
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273854 Compositions and methods for inhibiting nadph oxidase expression
10/28/2010US20100273851 Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
10/28/2010US20100273850 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273831 Fluoro alkyl substituted benzimidazole cannabinoid agonists
10/28/2010US20100273828 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
10/28/2010US20100273825 Solid pharmaceutical composition containing solifenacin amorphous form
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273790 Processes for the preparation of rivaroxaban and intermediates thereof
10/28/2010US20100273785 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273782 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273780 Substituted 8-heteroaryl xanthines
10/28/2010US20100273779 Pyridazinone Derivatives
10/28/2010US20100273768 Inhibitors of Bruton's Tyrosine Kinase
10/28/2010US20100273758 Sulfonamide Derivatives For The Treatment Of Diseases
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273755 Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
10/28/2010US20100273754 Organic compounds
10/28/2010US20100273753 Organic compounds
10/28/2010US20100273752 Mequitazine for treating or preventing pathologies involving histamine h4 receptors
10/28/2010US20100273751 Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/28/2010US20100273744 Compounds
10/28/2010US20100273712 Surfactant usage in lung transplantation and methods thereof
10/28/2010US20100273701 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
10/28/2010US20100273700 Use of a peptide as a therapeutic agent
10/28/2010US20100272838 Compositions comprising siraitia grosvenori extracts and methods for the treatment of infection
10/28/2010US20100272823 Pulmonary delivery particles comprising water insoluble or crystalline active agents
10/28/2010US20100272822 Nanocell drug delivery system
10/28/2010US20100272814 Method and means for producing bronchorelaxation
10/28/2010US20100272811 Complex of trospium and pharmaceutical compositions thereof
10/28/2010US20100272789 External medicine for treatment or prevention
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272739 Modulation of Gamma-Delta T Cells to Regulate Airway Hyperresponsiveness
10/28/2010US20100272735 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
10/28/2010US20100272733 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
10/28/2010US20100272722 Therapeutic uses of inhibitors of RTP801
10/28/2010US20100272685 Porcine Adeno-Associated Viruses
10/28/2010US20100272654 Levalbuterol salt
10/28/2010US20100272638 Radiolabelled microparticles, processes for the preparation thereof and the use thereof
10/28/2010US20100269825 Inhalation particles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1h)-quinolinone and a corticosteroid
10/28/2010CA2759874A1 Methods of treating a pulmonary bacterial infection using fluoroquinolones
10/28/2010CA2759611A1 Compositions and methods for the treatment of chronic obstructive pulmonary disease and asthma
10/28/2010CA2759583A1 A tuberculosis tb vaccine to prevent reactivation
10/28/2010CA2758985A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758968A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758729A1 Arylsulfonamide ccr3 antagonists
10/28/2010CA2758505A1 Diamide compounds having muscarinic receptor antagonist and .beta.2 adrenergic receptor agonist activity
10/27/2010EP2243781A1 Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases
10/27/2010EP2243778A1 Piperidine derivative
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP2243486A1 Adrenomedullin production enhancer
10/27/2010EP2242759A1 Compounds
10/27/2010EP2242477A2 Topically active steroids for use in interstitial pulmonary fibrosis
10/27/2010EP1907399B1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN1898231B Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN1649568B Pharmaceutical compositions for the treatment of asthma
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 878